Poison Pills and Shareholder Rights Plans

Poison Pills and Shareholder Rights Plans covers mergers, acquisitions, buyouts, SPAC transactions, deal consideration, takeover bids, defenses, divestitures, restructurings, turnarounds, and control transactions.

Use these pages when a transaction changes ownership, control, valuation, financing, assets, liabilities, shareholder rights, or business scope. It sits inside Takeover Defenses and Shareholder Rights, so readers can move up when the broader company-finance context matters.

Use the table below to choose the narrower corporate-finance branch before applying a term to a model, board memo, financing analysis, transaction review, or risk assessment. Move into the term page when the evidence source, calculation, agreement, filing, account, or governance right matters.

What This Branch Covers

What to Check

• Buyer, seller, target, acquirer, board, shareholder, creditor, or adviser involved.
• Letter of intent, merger agreement, tender offer, proxy, fairness opinion, financing commitment, or restructuring plan.
• Consideration form, valuation basis, premium, synergies, working capital, debt, earnout, and closing conditions.
• Approval thresholds, regulatory review, fiduciary duties, break fees, defenses, and integration risk.
• Effect on enterprise value, leverage, dilution, control, liquidity, taxes, accounting, and execution risk.

Common Mistakes

• Treating announcement value as final deal value.
• Ignoring closing conditions, financing risk, approvals, and competing bids.
• Mixing asset sales, mergers, tender offers, spin-offs, carve-outs, and restructurings.
• Assuming takeover-defense labels determine outcomes without board, shareholder, and legal context.

M&A content is educational and does not provide legal, tax, accounting, valuation, fairness-opinion, or transaction advice.

In this section

Choose a subsection first. Deeper term pages live inside each subsection, which keeps large topic hubs readable.